Cognitive Testing on Mobile & Wearable Devices

Size: px
Start display at page:

Download "Cognitive Testing on Mobile & Wearable Devices"

Transcription

1 Cognitive Testing on Mobile & Wearable Devices Krystyna Zaluski CANTAB Connect Prodromal Alzheimer s Background Cambridge Cognition All rights reserved Page 1

2 Overview A neuroscience digital health company - Measuring cognition accurately Validated by over 30 years of neuroscience research A measure of cognitive function in over 100 indications Trusted by the world s top pharmaceutical companies

3 Technology Platforms for Cognitive Testing Research tools Tools for clinical and research trials to detect effects of drugs and environmental changes At-home testing Cognitive tests that can be completed by participants at home High Frequency testing Frequent monitoring of cognitive ability using wearable devices In-clinic tools Cognitive assessments for clinical use that can identify those who require further investigation Neuroanalytics Consultancy We provide expertise in the design, analysis and interpretation of neuropsychological endpoints in cognitive studies and clinical trials with extensive experience using research and analytic approaches.

4 Overview CANTAB C O G N I T I V E S C I E N C E CANTAB has been used to assess over 250,000 Participants worldwide

5 Specific to Cognitive Domain

6 Specific to Neural Mechanisms Digital Biomarker Reaction Time Rapid Visual Information Processing Spatial Working Memory Episodic Memory

7 Worse performance score Sensitive to Disease State Cognitive Signature diagnosis AD MCI PD 1 0 AT_cat EF_cat EM_cat PS_cat WM_cat Attention Executive Function Episodic domain Memory Processing speed Working Memory

8 Cognition is subject to daily fluctuations

9 How to measure Cognition in the real world

10 Daily assessment across platforms and devices software enables an individual to complete an assessment on a range of mobile and wearable devices without having to visit a clinic or be helped by a health care professional. Drawing tasks to measure memory and executive function. Emotional recognition tasks to measure social cognition. N-back tasks to measure memory and attention.

11 Best Practice Approach Decisions are made with the individual in mind Patient Experience Cog Test Validity Cognitive test selection and adaptation designed with scientific rigor Large Data Sets of objective cognitive measurement and passive data points Meaningful Data

12 Validation Process Page 12

13 Developing a cognitive test for high-frequency testing N-back task activates a network of areas in the brain including frontal and parietal regions (Owen et al., 2005). There is significant variation across and within days on n-back performance, partly linked to mood and motivation (Brose et al., 2012). Rose & Ebmeier. Journal of affective disorders 90 (2006): Owen et al., Human brain mapping 25 (2005): Brose, Schmiedek, Lövdén & Lindenberger. Emotion 12 (2012): 605.

14 Phase 1: Proof of concept study in healthy volunteers Study design: 10 (4 females) aged Sensor data (heart rate, skin temperature, GSR) measured continuously between CANTAB tasks (SWM, RVP, AST, ERT) and the PANAS administered each day after 1700 Cognitive & mood assessment scheduled hourly Presentation = 600 ms ISI = 600 ms 2-back match Cormack et al, AAIC 2016

15 Baseline performance AST.correct RVPA RVP.False.Alarm age SWM.Errors linear intercept Phase 1: Detailed cognitive data 1-minute micro-tests capture meaningful across-time variation and correlate with gold-standard computerised tests. Revealed issues with device and dynamic range of the test. intercept 1 r= 0.52 linear age SWM.Errors v RVPA RVP.False. Alarm age AST.correct Cormack et al, AAIC 2016

16 Phase 2: Design refinement using web-based testing Findings from phase 1: A number of participants rapidly reached ceiling People were giving symbols names verbal recording of the stimuli, and familiarity with symbols over time Issues with the device used in the proof-of-concept: battery life, limited display, discontinuation Questions for phase 2: Change of symbol design and larger bank of symbols to reduce availability of verbal strategies Could we titrate the difficulty level without increasing the n: role of symbol complexity, timing parameters, and number of symbols Decision to use Apple iwatch

17 Phase 2: Participant Experience Refining task to increase dynamic range Converted task for web-based testing with redesigned stimuli Crowd-sourced A-B testing using Amazon m-turk Series of experiments exploring the impact of task parameters on participant performance using: Presentation time Symbol design Number of unique symbols n = 994 participants aged in total n = 88 also completed CANTAB Spatial Working memory test and CANTAB PAL (episodic memory)

18 Phase 2: Cognitive Test Validity Iterative A-B experimentation determined: Significant effect of stimulus presentation time on performance Significant impact of number of symbols in trial Symbol design (e.g. number of segments + arrangement) did not significantly impact performance r=-0.41 P<0.001 Correlations with CANTAB test significant association with SWM, but not PAL. r=-0.10 P=0.37 Confirms sensitivity to working memory performance.

19 Phase 3: In-person testing and iterative design Would the same parameters work on the watch? How would participants perform over an extended time? Is the paradigm and testing schedule tolerable? What are some of the barriers to compliance? How can we make sure that patients understand the app and the tasks? N=7 subjects over 3 weeks. Apple watch N-back testing x3 times a day

20 Cognitive Testing on Mobile & Wearable Devices CANTAB Connect Prodromal Alzheimer s Background Cambridge Cognition All rights reserved Page 20

Adaptive Design in CIAS

Adaptive Design in CIAS Adaptive Design in CIAS or If you don t know where you re going, any road will get you there Michael Sand, PhD, MPH Senior Clinical Program Leader, CNS Boehringer Ingelheim Disclosures I m an employee

More information

Schizophrenia Battery

Schizophrenia Battery Schizophrenia Battery Cantab Schizophrenia Battery A c c e l e r a t e t h e d e v e l o p m e n t o f s a f e a n d e f f e c t i v e m e d i c i n e s Fast, reliable and highly sensitive, the Cantab

More information

Cognitive Health in the Workplace

Cognitive Health in the Workplace Mild Cognitive Impairment: Uncovering the Impact on an Ageing Workforce Cognitive Health in the Workplace Dr Jenny Barnett Director, Healthcare Innovation CANTAB Corporate Health Validated by 30 years

More information

CANTAB Test descriptions by function

CANTAB Test descriptions by function CANTAB Test descriptions by function The 22 tests in the CANTAB battery may be divided into the following main types of task: screening tests visual memory tests executive function, working memory and

More information

INTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME

INTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME INTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls

More information

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER

DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER OVERCOMING THE CHALLENGES OF MANAGING CHRONIC DISEASES IN PERSONS WITH DEMENTIA DEMENTIA, THE BRAIN AND HOW IT WORKS AND WHY YOU MATTER LEARNING OBJECTIVES Be familiar with the diagnostic criteria for

More information

European Prevention of Alzheimer s Dementia (EPAD)

European Prevention of Alzheimer s Dementia (EPAD) European Prevention of Alzheimer s Dementia (EPAD) Ron Marcus, MD ISCTM Adaptive Design Workshop February 20, 2018 1 EPAD Goal The European Prevention of Alzheimer's Dementia (EPAD) project aims to develop

More information

Digital Biomarkers in Neurology. Digital Biomarkers Conference March 31, 2016

Digital Biomarkers in Neurology. Digital Biomarkers Conference March 31, 2016 Digital Biomarkers in Neurology Digital Biomarkers Conference March 31, 2016 Outline Rationale Smartphones in Parkinson disease Wearables in movement disorders Future 2 Outline Rationale Smartphones in

More information

NEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P

NEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P NEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P NEUROPSYCHOLOGICAL EXAMINATION A method of examining the brain; abnormal behavior is linked to

More information

Collaborating to Develop Digital Biomarkers with Passive Data Collection

Collaborating to Develop Digital Biomarkers with Passive Data Collection Collaborating to Develop Digital Biomarkers with Passive Data Collection Iain Simpson IXICO June 2018 1 Setting of Data Collection Market evolution: biosensors and digital biomarkers Clinic Home Digital

More information

Regulatory Challenges across Dementia Subtypes European View

Regulatory Challenges across Dementia Subtypes European View Regulatory Challenges across Dementia Subtypes European View Population definition including Early disease at risk Endpoints in POC studies Endpoints in pivotal trials 1 Disclaimer No CoI The opinions

More information

An Introduction to the CBS Health Cognitive Assessment

An Introduction to the CBS Health Cognitive Assessment An Introduction to the CBS Health Cognitive Assessment CBS Health is an online brain health assessment service used by leading healthcare practitioners to quantify and objectively 1 of 9 assess, monitor,

More information

Biological Risk Factors

Biological Risk Factors Biological Risk Factors Ms Angelina Crea Provisional Psychologist Academic Child Psychiatry Unit Royal Children s Hospital Professor Alasdair Vance Head Academic Child Psychiatry Department of Paediatrics

More information

Neuropsychology and Parkinson s Disease. Erin Holker, Ph.D., ABPP Neuropsychology Laboratory

Neuropsychology and Parkinson s Disease. Erin Holker, Ph.D., ABPP Neuropsychology Laboratory Neuropsychology and Parkinson s Disease Erin Holker, Ph.D., ABPP Neuropsychology Laboratory Parkinson s disease and cognition Parkinson s disease is not just a disorder of movement The same circuits associated

More information

Wearable Devices and Smoking Cessation: What Have We Learned About Using Wearables in Behavior Change Research? Susan Murphy

Wearable Devices and Smoking Cessation: What Have We Learned About Using Wearables in Behavior Change Research? Susan Murphy Wearable Devices and Smoking Cessation: What Have We Learned About Using Wearables in Behavior Change Research? Susan Murphy 02.21.17 Much Promise for Health Behavior Change! Eating disorders (e.g., Bauer

More information

Outcome measures in neuroscience clinical trials

Outcome measures in neuroscience clinical trials Neuroscience TM Outcome measures in neuroscience clinical trials Jang-Ho Cha, Head, Translational Medicine Neuroscience Novartis Institute for BioMedical Research February 2017 Outline What is our problem?

More information

Translational Clinical Science

Translational Clinical Science Translational Clinical Science Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal Children s Hospital Outline of Presentation 1. Translational Clinical

More information

THE ICA INTEGRATED COGNITIVE ASSESSMENT TACKLING DEMENTIA WHEN IT COUNTS

THE ICA INTEGRATED COGNITIVE ASSESSMENT TACKLING DEMENTIA WHEN IT COUNTS THE ICA INTEGRATED COGNITIVE ASSESSMENT AI TACKLING DEMENTIA WHEN IT COUNTS 1 CONTENTS INTRODUCTION WHO WE ARE CURRENT ISSUES THE ICA BENEFITS MILESTONES MEDIA PRESCENCE 03 04 05 06 11 16 18 2 DEMENTIA

More information

Movement and Memory. Undergraduate degree. Technology & Movement: New Approaches to Understanding Change. Graduate degree

Movement and Memory. Undergraduate degree. Technology & Movement: New Approaches to Understanding Change. Graduate degree Tracy Zitzelberger, MPH Technology & Movement: New Approaches to Understanding Change Tracy Zitzelberger, MPH Administra9ve Director Layton Aging & Alzheimer's Disease Center Oregon Center for Aging &

More information

PS3021, PS3022, PS4040

PS3021, PS3022, PS4040 School of Psychology Important Degree Information: B.Sc./M.A. Honours The general requirements are 480 credits over a period of normally 4 years (and not more than 5 years) or part-time equivalent; the

More information

ADHD in children and adolescents: examination of the association of neurological subtle signs with working memory problems

ADHD in children and adolescents: examination of the association of neurological subtle signs with working memory problems ADHD in children and adolescents: examination of the association of neurological subtle signs with working memory problems Winther, J., Aggarwal, S., Hall, N, Rennie, K., C Prakash, Williams, J., & Vance,

More information

CYGNUS: A digital brain health platform for improving dementia outcomes

CYGNUS: A digital brain health platform for improving dementia outcomes CYGNUS: A digital brain health platform for improving dementia outcomes Léa Marais - IXICO Hakim Yadi - Northern Health Science Alliance www.ecygnus.com Background to Cygnus Many people with dementia are

More information

CTIS-Adverse Effects

CTIS-Adverse Effects White Paper CTIS-Adverse Effects A new Clinical Trial Information System for assessing cognitive safety in Phase I drug trials Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition 2 CTIS-Adverse

More information

ERP Feature of Vigilance. Zhendong Mu

ERP Feature of Vigilance. Zhendong Mu 5th International Conference on Education, Management, Information and Medicine (EMIM 205) ERP Feature of Vigilance Zhendong Mu Institute of Information Technology, Jiangxi University of Technology, Nanchang,

More information

Early intervention in Bipolar Disorder

Early intervention in Bipolar Disorder Early intervention in Bipolar Disorder Lakshmi N. Yatham MBBS, FRCPC, MRCPsych Professor of Psychiatry, University of British Columbia, Vancouver, Canada Early Intervention in Bipolar Disorder High Risk

More information

The future of diabetes clinical trials

The future of diabetes clinical trials The future of diabetes clinical trials Continuous glucose monitoring (CGM) for diabetes management and research Photography by Isy & Leigh Anderson and Alden Chadwick Introduction The latest technology

More information

La cognizione sociale

La cognizione sociale 15 Aprile 2015 - Firenze La cognizione sociale Chiara Cerami Divisione di Neuroscienze, Istituto Scientifico San Raffaele e Università Vita-Salute San Raffaele, Milano, Italy Theoretical Background Social

More information

presents Approach to Dementia Care

presents Approach to Dementia Care presents The I m Still Here Approach to Dementia Care www.thehearth.org 888 422 CARE 1 2 I m Still Here : Activity Programming for Persons with Dementia Presented by Hearthstone Alzheimer Care I m Still

More information

Augmented Cognition to enhance human sensory awareness, cognitive functioning and psychic functioning: a research proposal in two phases

Augmented Cognition to enhance human sensory awareness, cognitive functioning and psychic functioning: a research proposal in two phases Augmented Cognition to enhance human sensory awareness, cognitive functioning and psychic functioning: a research proposal in two phases James Lake MD (egret4@sbcglobal.net) Overview and objectives Augmented

More information

Neuropsychology of Attention Deficit Hyperactivity Disorder (ADHD)

Neuropsychology of Attention Deficit Hyperactivity Disorder (ADHD) Neuropsychology of Attention Deficit Hyperactivity Disorder (ADHD) Ronna Fried, Ed.D. Director of Neuropsychology Clinical & Research Programs in Pediatric Psychopharmacology and Adult ADHD Massachusetts

More information

Neuropsychological Evaluation of

Neuropsychological Evaluation of Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish

More information

Mentis Cura November

Mentis Cura November Mentis Cura November 29 2012 www.mentiscura.com New Facts on Alzheimer s Death rank nr. 2-5 in western countries Fastest growing disease in: Cost Incedence Death rate People with Alzheimer s 2012 36 million

More information

Conscious control of movements: increase of temporal precision in voluntarily delayed actions

Conscious control of movements: increase of temporal precision in voluntarily delayed actions Acta Neurobiol. Exp. 2001, 61: 175-179 Conscious control of movements: increase of temporal precision in voluntarily delayed actions El bieta Szel¹g 1, Krystyna Rymarczyk 1 and Ernst Pöppel 2 1 Department

More information

Beyond the Psychologist s Report. Nancy Foster, PhD Institute for Brain-Behavior Integration

Beyond the Psychologist s Report. Nancy Foster, PhD Institute for Brain-Behavior Integration Beyond the Psychologist s Report human mental processes are complex functional systems that are not localized in narrow, circumscribed areas of the brain, but take place through the participation of groups

More information

Human Factors & User Experience LAB

Human Factors & User Experience LAB Human Factors & User Experience LAB User Experience (UX) User Experience is the experience a user has when interacting with your product, service or application Through research and observation of users

More information

Service Related Project. Kimberley Keegan

Service Related Project. Kimberley Keegan AN EVALUATION OF ADDENBROOKE S COGNITIVE EXAMINATION III (ACE-III) SCORES, NEUROPSYCHOLOGICAL ASSESSMENT SCORES, AND DIAGNOSIS OUTCOME WITHIN A MEMORY SERVICE. Service Related Project Kimberley Keegan

More information

TestMyBrain Consulting for RDoC Field Test Battery

TestMyBrain Consulting for RDoC Field Test Battery TestMyBrain Consulting for RDoC Field Test Battery TABLE OF CONTENTS 1. Overview... 2 3 2. Summary of Measures... 4 6 3. TMB Anger Sensitivity... 7 4. TMB Choice Reaction Time... 12 5. TMB Delay Discounting...

More information

MSc Neuroimaging for Clinical & Cognitive Neuroscience

MSc Neuroimaging for Clinical & Cognitive Neuroscience MSc Neuroimaging for Clinical & Cognitive Neuroscience School of Psychological Sciences Faculty of Medical & Human Sciences Module Information *Please note that this is a sample guide to modules. The exact

More information

Comparing MCI Patients to Healthy Controls using Three ERP Paradigms

Comparing MCI Patients to Healthy Controls using Three ERP Paradigms Comparing MCI Patients to Healthy Controls using Three ERP Paradigms Electrophysiology PIA AAIC 2015 Washington, DC Frank Knoefel, Rocío López Zunini, Vanessa Taler, Michael Breau, Lisa Sweet, Courtney

More information

Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS

Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS Changes, Challenges and Solutions: Overcoming Cognitive Deficits after TBI Sarah West, Ph.D. Hollee Stamper, LCSW, CBIS Learning Objectives 1. Be able to describe the characteristics of brain injury 2.

More information

APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA

APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA APPENDIX A TASK DEVELOPMENT AND NORMATIVE DATA The normative sample included 641 HIV-1 seronegative gay men drawn from the Multicenter AIDS Cohort Study (MACS). Subjects received a test battery consisting

More information

What Medicine can Learn from Marketing

What Medicine can Learn from Marketing What Medicine can Learn from Marketing A Consumerist Approach to Re-Branding Re-Designing & Re-Organizing Primary Care Zeev Neuwirth, MD Senior Medical Director Population Health Carolinas HealthCare System

More information

Towards scientific validated digital biomarkers measured by patient's own smart devices: cases studies from Parkinson's disease and Multiple Sclerosis

Towards scientific validated digital biomarkers measured by patient's own smart devices: cases studies from Parkinson's disease and Multiple Sclerosis Towards scientific validated digital biomarkers measured by patient's own smart devices: cases studies from Parkinson's disease and Multiple Sclerosis Christian Gossens, PhD, MBA, Global Head Digital Biomarkers,

More information

Challenges in Developing Learning Algorithms to Personalize mhealth Treatments

Challenges in Developing Learning Algorithms to Personalize mhealth Treatments Challenges in Developing Learning Algorithms to Personalize mhealth Treatments JOOLHEALTH Bar-Fit Susan A Murphy 01.16.18 HeartSteps SARA Sense 2 Stop Continually Learning Mobile Health Intervention 1)

More information

Complexity Made Simple

Complexity Made Simple Complexity Made Simple Bussey-Saksida Touch Screen Chambers for Rats and Mice Tasks translate directly to well established monkey and human touch models e.g. CANTAB High throughput screening of multiple

More information

Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI

Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI Exploration of a weighed cognitive composite score for measuring decline in amnestic MCI Sarah Monsell NACC biostatistician smonsell@uw.edu October 6, 2012 Background Neuropsychological batteries used

More information

Cognizanti. You Don t Join Us; We Join You. Insurance/Health & Wellness VOLUME

Cognizanti. You Don t Join Us; We Join You. Insurance/Health & Wellness VOLUME Cognizanti VOLUME 11 2018 Insurance/Health & Wellness You Don t Join Us; We Join You Insurance/Health & Wellness You Don t Join Us; We Join You By Steve Roberts The success of a new healthcare business

More information

Web Usability Testing With Concurrent fnirs and Eye Tracking

Web Usability Testing With Concurrent fnirs and Eye Tracking Chapter 30 Web Usability Testing With Concurrent fnirs and Eye Tracking Siddharth Bhatt 1, Atahan Agrali 1, Kevin McCarthy 1, Rajneesh Suri 1, Hasan Ayaz 1,2,3 1 Drexel University, Philadelphia, PA, United

More information

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME PERNECZKY 15/06/06 14:35 Page 1 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME R. PERNECZKY, A. KURZ Department of Psychiatry and Psychotherapy, Technical University of Munich, Germany. Correspondence

More information

GLUCOMETER: High Level Design

GLUCOMETER: High Level Design Fall 2014 High Level Design 1 GLUCOMETER: High Level Design Electrical Engineers: Michael Williams, Christopher Homa, Matthew Henne Mechanical Engineer: Ish Amagashie Software Engineer: Sofyan Saputra

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

Communication Access Features on Apple devices

Communication Access Features on Apple devices Communication Access Features on Apple devices The information in this guide is correct for devices running ios 10. Devices running earlier operating systems may differ. Page 2 Page 3 Page 4 Page 5 Page

More information

Clinical Trial Glossary

Clinical Trial Glossary Clinical Trial Glossary Adverse event An unfavorable change in health that can occur during a clinical trial or study or within a certain time period after. These can range from mild (e.g., nausea) to

More information

Addressing Gaps in MS Care. November 6, :00 AM - Noon

Addressing Gaps in MS Care. November 6, :00 AM - Noon Addressing Gaps in MS Care November 6, 2015 11:00 AM - Noon Learning Objectives Understand and confidently communicate the barriers to MS care caused by the shortage of healthcare providers with MS experience,

More information

The Neuropsychological Impairment Scale (NIS) Self-Report Form

The Neuropsychological Impairment Scale (NIS) Self-Report Form The Neuropsychological Impairment Scale (NIS) Self-Report Form A WPS TEST REPORT by William E O Donnell, PhD, MPH Copyright 1999 by Western Psychological Services wwwwpspublishcom Version 1110 ID Number:

More information

Electronic Care Centre for Caregivers of Patients with Alzheimer's disease

Electronic Care Centre for Caregivers of Patients with Alzheimer's disease Electronic Care Centre for Caregivers of Patients with Alzheimer's disease Hippokratis Apostolidis1, Thrasyvoulos Tsiatsos1, Konstantina Karagkiozi2, Tatiana Dimitriou3, Magdalini Tsolaki3 1 Department

More information

The Brain is Still a Mystery. National Institutes of Health 7/11/2012

The Brain is Still a Mystery. National Institutes of Health 7/11/2012 Early Brain Development, Early Education, and the Development of Executive Function Skills James A. Griffin, PhD NIH/NICHD National Institutes of Health World s largest supporter of biomedical, behavioral,

More information

Alzheimer s disease dementia: a neuropsychological approach

Alzheimer s disease dementia: a neuropsychological approach Alzheimer s disease dementia: a neuropsychological approach Dr. Roberta Biundo, PhD Neuropsychology Coordinator at Parkinson s disease and movement disorders unit of San Camillo rehabilitation hospital

More information

Why ICT are interesting for Frailty

Why ICT are interesting for Frailty Why ICT are interesting for Frailty Philippe Robert 1,2, Patrick Malléa 1,, Valeria Manera 1,, Alexandra Konig 1,, Renaud David 1,2 1 EA CoBTeK / IA, University of Nice Sophia Antipolis, France 2 Centre

More information

The value of the CANTAB battery in evaluating

The value of the CANTAB battery in evaluating The value of the CANTAB battery in evaluating cognitive disorders in epileptic patients Abstract Epileptic process generate, depends on the cerebral region affected, a variety of neurological impairements,

More information

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018 Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been

More information

IQ Tests, IQ Augmenting Technologies & How To Join Mensa

IQ Tests, IQ Augmenting Technologies & How To Join Mensa IQ Tests, IQ Augmenting Technologies & How To Join Mensa Mark Ashton Smith, Ph.D. 2015 HRP Lab, UK Chapter 2. IQ Augmenting Technologies Computerized Cognitive Training (CCT) Generally what we understand

More information

sensors ISSN

sensors ISSN Supplementary Information OPEN ACCESS sensors ISSN 1424-8220 www.mdpi.com/journal/sensors A Review of Brain-Computer Interface Games and an Opinion Survey from Researchers, Developers and Users. Sensors

More information

NEUROCOGNITIVE, OUTCOMES IN PKU: IT S TIME TO RAISE THE BAR

NEUROCOGNITIVE, OUTCOMES IN PKU: IT S TIME TO RAISE THE BAR NEUROCOGNITIVE, OUTCOMES IN : IT S TIME TO RAISE THE BAR KEY POINTS 1. High Phenylalanine (Phe) levels harm the brain.. Traditional therapies do not completely protect individuals with. 3. New approaches

More information

Running head: MOOD AND COGNITION IN EVERYDAY LIFE 1. Mood Effects on Memory and Executive Control in a Real-Life Situation

Running head: MOOD AND COGNITION IN EVERYDAY LIFE 1. Mood Effects on Memory and Executive Control in a Real-Life Situation Running head: MOOD AND COGNITION IN EVERYDAY LIFE 1 Mood Effects on Memory and Executive Control in a Real-Life Situation Prune Lagner 1, Matthias Kliegel 1, Louise H. Phillips 2, Andreas Ihle 1, Alexandra

More information

2.0 Synopsis. Levodopa-Carbidopa Intestinal Gel M Clinical Study Report R&D/15/1285. (For National Authority Use Only)

2.0 Synopsis. Levodopa-Carbidopa Intestinal Gel M Clinical Study Report R&D/15/1285. (For National Authority Use Only) 2.0 Synopsis AbbVie Inc. Name of Study Drug: Levodopa Carbidopa Intestinal Gel (LCIG) Name of Active Ingredient: Levodopa-Carbidopa Individual Study Table Referring to Part of Dossier: Volume: Page: (For

More information

Using the Person-based Approach. cognitive decline. Dr Alex Milton, Psychology

Using the Person-based Approach. cognitive decline. Dr Alex Milton, Psychology Using the Person-based Approach to intervention Qualitative research design: at later The RECON development Project for stages reducing cognitive decline Dr Alex Milton, Psychology Overview 1. Introduction

More information

So, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International

So, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International So, My FitBit is Clinical Trial Grade Right? Keith Wenzel Senior Director, Solution Incubator PAREXEL International 1 Disclaimer The views and opinions expressed in the following PowerPoint slides are

More information

Effects of simultaneously performed cognitive and physical training in older adults

Effects of simultaneously performed cognitive and physical training in older adults Theill et al. BMC Neuroscience 2013, 14:103 RESEARCH ARTICLE Effects of simultaneously performed cognitive and physical training in older adults Nathan Theill 1,2*, Vera Schumacher 1,2,3, Rolf Adelsberger

More information

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University

Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Ian McKeith MD, F Med Sci, Professor of Old Age Psychiatry, Newcastle University Design of trials in DLB and PDD What has been learnt from previous trials in these indications and other dementias? Overview

More information

Why Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills

Why Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills Why Cognition Matters: Impact of Cognitive Impairment on Safety and Independent Living Skills Presented by: Dr. William Mansbach CEO & Founder Mansbach Health Tools, LLC www.thebcat.com Highlights on Prevalence

More information

Fundamentals of Cognitive Psychology, 3e by Ronald T. Kellogg Chapter 2. Multiple Choice

Fundamentals of Cognitive Psychology, 3e by Ronald T. Kellogg Chapter 2. Multiple Choice Multiple Choice 1. Which structure is not part of the visual pathway in the brain? a. occipital lobe b. optic chiasm c. lateral geniculate nucleus *d. frontal lobe Answer location: Visual Pathways 2. Which

More information

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why? Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric

More information

Evoked Response Potential Latency Modeling and Production Time Prediction

Evoked Response Potential Latency Modeling and Production Time Prediction / APPROVED FOR PUBLIC RELEASE Evoked Response Potential Latency Modeling and Production Time Prediction Daniel Cassenti, U.S. Army Research Laboratory ACT-R Post-Graduate Summer School / APPROVED FOR PUBLIC

More information

Capacity and Older Adults. Kenneth I. Shulman

Capacity and Older Adults. Kenneth I. Shulman Capacity and Older Adults Kenneth I. Shulman Increased Requests for Contemporaneous Assessments of Testamentary Capacity Increase in challenges to testamentary capacity Demographics/Economics Prevalence

More information

Table 1: Summary of measures of cognitive fatigability operationalised in existing research.

Table 1: Summary of measures of cognitive fatigability operationalised in existing research. Table 1: Summary of measures of cognitive fatigability operationalised in existing research. Candidate Mmeasures Studies Procedure Self-reported fatigue measure Key Findings The auditory As and auditory

More information

The Neuropsychology of

The Neuropsychology of The Neuropsychology of Stroke Tammy Kordes, Ph.D. Northshore Neurosciences Outline What is the Role of Neuropsychology Purpose of Neuropsychological Assessments Common Neuropsychological Disorders Assessment

More information

Recognizing and Managing the Emotional Aspects of Parkinson s. Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker

Recognizing and Managing the Emotional Aspects of Parkinson s. Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker Recognizing and Managing the Emotional Aspects of Parkinson s Pamela R. Palmentera, LCSW Coordinator & Clinical Social Worker Sensory information from the one hemisphere crosses over to the other side

More information

Effect of real-time monitoring and notification

Effect of real-time monitoring and notification Effect of real-time monitoring and notification of smoking episodes on smoking reduction A pilot study of a novel smoking cessation app Reuven Dar ruvidar@post.tau.ac.il The Problem Need to provide highly

More information

CNADC NIA ADC Clinical Task Force UDS Neuropsychology Work Group April 2011

CNADC NIA ADC Clinical Task Force UDS Neuropsychology Work Group April 2011 NIA ADC Clinical Task Force UDS Neuropsychology Work Group April 2011 Members: Hiroko Dodge (OHSU) Steven Ferris (NYU) Joel Kramer (UCSF) Ex Officio David Loewenstein (Miami) Po Lu (UCLA) Bruno Giordani

More information

Discovering Breakthrough Treatments for Human Disease. Discovering Breakthrough Treatments for Human Disease

Discovering Breakthrough Treatments for Human Disease. Discovering Breakthrough Treatments for Human Disease Patient Reported Outcomes in Oncology Trials Pablo Lapuerta, MD Executive Vice President and Chief Medical Officer Discovering Breakthrough Treatments for Human Disease Discovering Breakthrough Treatments

More information

WP 7: Emotion in Cognition and Action

WP 7: Emotion in Cognition and Action WP 7: Emotion in Cognition and Action Lola Cañamero, UH 2 nd Plenary, May 24-27 2005, Newcastle WP7: The context Emotion in cognition & action in multi-modal interfaces? Emotion-oriented systems adapted

More information

Beyond AI: Bringing Emotional Intelligence to the Digital

Beyond AI: Bringing Emotional Intelligence to the Digital Beyond AI: Bringing Emotional Intelligence to the Digital World Emotions influence every aspect of our lives how we live, work and play to the decisions we make We are surrounded by hyper-connected devices,

More information

FINAL PROGRESS REPORT

FINAL PROGRESS REPORT (1) Foreword (optional) (2) Table of Contents (if report is more than 10 pages) (3) List of Appendixes, Illustrations and Tables (if applicable) (4) Statement of the problem studied FINAL PROGRESS REPORT

More information

Wearable Devices for Heart Disease, Sleep Apnea, and Health. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System

Wearable Devices for Heart Disease, Sleep Apnea, and Health. Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System Wearable Devices for Heart Disease, Sleep Apnea, and Health Jia Shen MD, MPH Assistant Professor of Medicine UC San Diego Health System Disclosures I have no conflict of interest related to products presented

More information

Technology Innovation Alert. N o n - i n v a s i v e D i a b e t e s M o n i t o r i n g. 16 December 31 December, Published. Granted.

Technology Innovation Alert. N o n - i n v a s i v e D i a b e t e s M o n i t o r i n g. 16 December 31 December, Published. Granted. Technology Innovation Alert N o n - i n v a s i v e D i a b e t e s M o n i t o r i n g 16 December 31 December, 2018 3 10 1 1 Published 10 Granted 5 Inactive 0 Start ups Companies Universities Individuals

More information

The evox System. A medical device to measure and train the brain evox System

The evox System. A medical device to measure and train the brain evox System The A medical device to measure and train the brain 1-800-957-5520 What Is evox? The medical device to MEASURE & TRAIN brain function. Measure clinically-proven biomarkers Objectively track treatment success

More information

Revealing The Brain s Hidden Potential: Cognitive Training & Neurocognitive Plasticity. Introduction

Revealing The Brain s Hidden Potential: Cognitive Training & Neurocognitive Plasticity. Introduction Revealing The Brain s Hidden Potential: Cognitive Training & Neurocognitive Plasticity. Introduction Global aging poses significant burdens as age-related impairments in cognitive function affect quality

More information

UNLOCKING THE MYSTERIES OF THE BRAIN

UNLOCKING THE MYSTERIES OF THE BRAIN UNLOCKING THE MYSTERIES OF THE BRAIN what is the language of the brain and how do we begin to decode it... THAT IS the challenge of the century. Today s researchers recognize that neural circuits are the

More information

NeuroTracker Published Studies & Research

NeuroTracker Published Studies & Research NeuroTracker Published Studies & Research Evidence of Relevance in Measurement, Learning and Transfer for Learning and Learning Related Conditions NeuroTracker evolved out of a pure science approach through

More information

iage: PERSONALIZED TECHNOLOGIES FOR FACILITATING HEALTH, WELLNESS AND SUCCESSFUL AGING

iage: PERSONALIZED TECHNOLOGIES FOR FACILITATING HEALTH, WELLNESS AND SUCCESSFUL AGING iage: PERSONALIZED TECHNOLOGIES FOR FACILITATING HEALTH, WELLNESS AND SUCCESSFUL AGING Binh Q. Tran, Ph.D. Director, HomeCare & Telerehabilitation Technology Center Department of Biomedical Engineering

More information

Practical Application using Behavior-Based Ergonomics Therapy (BBET) Program

Practical Application using Behavior-Based Ergonomics Therapy (BBET) Program Award-Winning Neuroscience Approach to Alzheimer s / Dementia Care of Residents Objectives 1. Discuss the research basis for cognitive ergonomics and neuroscience in Alzheimer s disease / dementia. 2.

More information

Cancer and Cognitive Functioning: Strategies for Improvement

Cancer and Cognitive Functioning: Strategies for Improvement Cancer and Cognitive Functioning: Strategies for Improvement Myron Goldberg, Ph.D., ABPP-CN Clinical Neuropsychologist Director, Neuro-Rehabilitation Program Department of Rehabilitation Medicine University

More information

Alzheimer s Disease Research

Alzheimer s Disease Research PRA INSIGHTS REPORT Alzheimer s Disease Research JULY 2017 Page 01 of 9 TABLE OF CONTENTS Introduction Methodology Summary Question One: Demographics Question Two: The Foremost Challenge in Neuroscience

More information

Where No Interface Has Gone Before: What Can the Phaser Teach Us About Label Usage in HCI?

Where No Interface Has Gone Before: What Can the Phaser Teach Us About Label Usage in HCI? Where No Interface Has Gone Before: What Can the Phaser Teach Us About Label Usage in HCI? Franklin P. Tamborello, II Phillip H. Chung Michael D. Byrne Rice University Department of Psychology 61 S. Main,

More information

KNOWLEDGE VALORIZATION

KNOWLEDGE VALORIZATION KNOWLEDGE VALORIZATION The goal of this valorisation chapter is to describe how the knowledge resulting from the research in this dissertation can be made valuable for clinical and social use. This dissertation

More information

Regional Grey Matter Atrophy is associated with Social Cognition impairment in Progressive Multiple Sclerosis (MS).

Regional Grey Matter Atrophy is associated with Social Cognition impairment in Progressive Multiple Sclerosis (MS). Escuela de Medicina Regional Grey Matter Atrophy is associated with Social Cognition impairment in Progressive Multiple Sclerosis (MS). Escuela de Medicina Tomas Labbe(1), Ethel Ciampi(2), Juan Pablo Cruz(3),

More information

Assessing cognitive function after stroke. Glyn Humphreys

Assessing cognitive function after stroke. Glyn Humphreys Assessing cognitive function after stroke Glyn Humphreys (glyn.humphreys@psy.ox.ac.uk) Write down 3 important cognitive problems after stroke What things are important to detect? OCS Impairment incidences

More information

Neuro Q no.2 = Neuro Quotient

Neuro Q no.2 = Neuro Quotient TRANSDISCIPLINARY RESEARCH SEMINAR CLINICAL SCIENCE RESEARCH PLATFORM 27 July 2010 School of Medical Sciences USM Health Campus Neuro Q no.2 = Neuro Quotient Dr.Muzaimi Mustapha Department of Neurosciences

More information